B+
Bull case
25%
Probability
Target price
$2.20
Analysis reference price unavailable
Analysis 2026-04-15 · RankAlpha Sentiment Codex
QNCX
Quince TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
The remaining upside case is no longer tied to eDSP development after Quince said the Phase 3 NEAT study missed primary and key secondary endpoints and that it would cease clinical development, preserve cash, and explore options; upside now rests on whether the cleaned-up balance sheet and strategic review produce a value-accretive transaction [#PR-2026-01-29][#PR-2026-03-30][#PR-2026-02-09].
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.0.
What can break
Low coverage and thin liquidity can cause sharp price moves disconnected from intrinsic value.
Momentum
74
Value
57
Sentiment
0
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.90 · Bull $2.20 · Bear $0.35Analysis 2026-04-15; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-11 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-11
Investment thesis
As of 2026-09-11
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-11. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $77.20
Why
Momentum74 · Δ7d -
Value57 · Δ7d -0.0
Sentiment0 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.0.
Contradictions & invalidation
- • Low coverage and thin liquidity can cause sharp price moves disconnected from intrinsic value.
- • Post-reverse-split trading can amplify volatility and does not by itself solve underlying fundamental weakness.
- • The bear case is that the failed pivotal study removed the operating thesis, the company is in restructuring mode, and the 10-K explicitly raises substantial doubt about going concern status, so any standalone path likely requires dilutive financing or a weakly priced transaction [#PR-2026-01-29][#10-K-2026-04-10].
Catalyst clock
2026-05-31
Post-reverse-split trading and listing stabilization
Lead driver: Value · See fundamentals
Momentum
74
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
57
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+16.2
Sentiment
0
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 74.5 / Value 57.3 / Sentiment 0.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-04-15. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$0.90
Analysis reference price unavailable
Analysis 2026-04-15 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$0.35
Analysis reference price unavailable
Analysis 2026-04-15 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$34.7M
Beta
1.24
Shares Out
1.02M
P/E (TTM) · Derived
-0.1
P/S (TTM)
-
P/FCF (TTM) · Derived
-0.36
Rev YoY
-
EPS YoY
-82.1%
Gross Margin
-
Op Margin
-
Net Debt
$719K
Current Ratio
14.52
As of 2026-09-11 • Updated nightlySource: Internal modelMethods & Data